Please assess the completion status of the following clinical trial:

Trial Title: MRI Evaluation of the Breast Areolar Margin and Paryenchyma

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Have one of the following indications for MRI study of the breast - screening for high risk without evidence of disease, have existing breast cancer with need for evaluation of extent of disease or to rule out additional occult cancer, or to have an equivocal mammogram or ultrasound requiring additional information from MRI.~* No prior breast surgery including prior excisional biopsies for disease performed with surgical technique, breast augmentation, reduction mammoplasty or breast lift with or without implants.~* Capable of fitting into the MRI machine.~* Permission to contact and consent the patient to participate from the investigator(s)~* Provide written informed consent and Authorization for Use/Disclosure of PHI~Exclusion Criteria:~* Have a contraindication to MRI study.~* Prior breast surgery - this includes: prior excisional biopsies for disease performed with surgical technique, breast augmentation, reduction mammoplasty or breast lift with or without implants \[Patients may have undergone prior percutaneous (needle) biopsy or fine needle aspiration\]~* Inability to fit into the MRI machine.~* Psychological factors that may interfere with successful completion of the study~* Refusal to provide written informed consent and/or Authorization for Use/Disclosure of PHI

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- MRI (Type: OTHER): All patients on study will undergo an MRI of the breast(s).

Based on this trial design, predict the completion outcome and termination type (if applicable).